Literature DB >> 16581806

Recognition of RNA by the p53 tumor suppressor protein in the yeast three-hybrid system.

Kasandra J-L Riley1, Laura A Cassiday, Akash Kumar, L James Maher.   

Abstract

The p53 tumor suppressor protein is a homotetrameric transcription factor whose gene is mutated in nearly half of all human cancers. In an unrelated screen of RNA/protein interactions using the yeast three-hybrid system, we inadvertently detected p53 interactions with several different RNAs. A literature review revealed previous reports of both sequence-specific and -non-specific interactions between p53 and RNA. Using yeast three-hybrid selections to identify preferred RNA partners for p53, we failed to identify primary RNA sequences or obvious secondary structures required for p53 binding. The cationic p53 C-terminus was shown to be required for RNA binding in yeast. We show that while p53 strongly discriminates between certain RNAs in the yeast three-hybrid assay, the same RNAs are bound equally by p53 in vitro. We further show that the p53 RNA-binding preferences in yeast are mirrored almost exactly by a recombinant tetrameric form of the HIV-1 nucleocapsid (NC) protein thought to be a sequence-nonspecific RNA-binding protein. However, the possibility of specific RNA binding by p53 could not be ruled out because p53 and HIV-1 NC displayed certain differences in RNA-binding preference. We conclude that (1) p53 binds RNA in vivo, (2) RNA binding by p53 is largely sequence-nonspecific in the yeast nucleus, (3) some structure-specific RNA binding by p53 cannot be ruled out, and (4) caution is required when interpreting results of RNA screens in the yeast three-hybrid system because sequence-dependent differences in RNA folding and display can masquerade as sequence-dependent differences in protein recognition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16581806      PMCID: PMC1421098          DOI: 10.1261/rna.2286706

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  61 in total

1.  RNA-protein interactions in the yeast three-hybrid system: affinity, sensitivity, and enhanced library screening.

Authors:  Brad Hook; David Bernstein; Beilin Zhang; Marvin Wickens
Journal:  RNA       Date:  2004-12-21       Impact factor: 4.942

2.  Modulation of binding of DNA to the C-terminal domain of p53 by acetylation.

Authors:  Assaf Friedler; Dmitry B Veprintsev; Stefan M V Freund; Karoly I von Glos; Alan R Fersht
Journal:  Structure       Date:  2005-04       Impact factor: 5.006

3.  Alternatively spliced forms in the carboxy-terminal domain of the p53 protein regulate its ability to promote annealing of complementary single strands of nucleic acids.

Authors:  L Wu; J H Bayle; B Elenbaas; N P Pavletich; A J Levine
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

4.  DNA binding specificity of proteins derived from alternatively spliced mouse p53 mRNAs.

Authors:  Z Miner; M Kulesz-Martin
Journal:  Nucleic Acids Res       Date:  1997-04-01       Impact factor: 16.971

5.  Recombination-mediated PCR-directed plasmid construction in vivo in yeast.

Authors:  K R Oldenburg; K T Vo; S Michaelis; C Paddon
Journal:  Nucleic Acids Res       Date:  1997-01-15       Impact factor: 16.971

Review 6.  P53 and prognosis: new insights and further complexity.

Authors:  Karen H Vousden; Carol Prives
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

7.  Interhelical angles in the solution structure of the oligomerization domain of p53: correction.

Authors:  G M Clore; J G Omichinski; K Sakaguchi; N Zambrano; H Sakamoto; E Appella; A M Gronenborn
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

8.  Specific interactions between HIV-1 nucleocapsid protein and the TAR element.

Authors:  Igor Kanevsky; Françoise Chaminade; Damien Ficheux; Abdeladim Moumen; Robert Gorelick; Matteo Negroni; Jean-Luc Darlix; Philippe Fossé
Journal:  J Mol Biol       Date:  2005-04-07       Impact factor: 5.469

9.  p53-dependent repression of CDK4 translation in TGF-beta-induced G1 cell-cycle arrest.

Authors:  M E Ewen; C J Oliver; H K Sluss; S J Miller; D S Peeper
Journal:  Genes Dev       Date:  1995-01-15       Impact factor: 11.361

10.  Escherichia coli proteins, including ribosomal protein S12, facilitate in vitro splicing of phage T4 introns by acting as RNA chaperones.

Authors:  T Coetzee; D Herschlag; M Belfort
Journal:  Genes Dev       Date:  1994-07-01       Impact factor: 11.361

View more
  13 in total

Review 1.  p53, a translational regulator: contribution to its tumour-suppressor activity.

Authors:  V Marcel; F Catez; J-J Diaz
Journal:  Oncogene       Date:  2015-03-02       Impact factor: 9.867

Review 2.  Selections that optimize RNA display in the yeast three-hybrid system.

Authors:  Susan E Wurster; L James Maher
Journal:  RNA       Date:  2009-12-14       Impact factor: 4.942

Review 3.  p53 RNA interactions: new clues in an old mystery.

Authors:  Kasandra J-L Riley; L James Maher
Journal:  RNA       Date:  2007-09-05       Impact factor: 4.942

4.  Analysis of p53-RNA interactions in cultured human cells.

Authors:  Kasandra J-L Riley; L James Maher
Journal:  Biochem Biophys Res Commun       Date:  2007-09-10       Impact factor: 3.575

5.  Nuclear retention of the lncRNA SNHG1 by doxorubicin attenuates hnRNPC-p53 protein interactions.

Authors:  Yuan Shen; Shanshan Liu; Jiao Fan; Yinghua Jin; Baolei Tian; Xiaofei Zheng; Hanjiang Fu
Journal:  EMBO Rep       Date:  2017-03-06       Impact factor: 8.807

Review 6.  Control of microRNA biogenesis and transcription by cell signaling pathways.

Authors:  Abil Saj; Eric C Lai
Journal:  Curr Opin Genet Dev       Date:  2011-05-16       Impact factor: 5.578

7.  p53 binds the mdmx mRNA and controls its translation.

Authors:  A-S Tournillon; I López; L Malbert-Colas; S Findakly; N Naski; V Olivares-Illana; K Karakostis; B Vojtesek; K Nylander; R Fåhraeus
Journal:  Oncogene       Date:  2016-07-04       Impact factor: 9.867

8.  p73alpha isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cells.

Authors:  Emilie Horvilleur; Matthieu Bauer; David Goldschneider; Xénia Mergui; Alix de la Motte; Jean Bénard; Sétha Douc-Rasy; David Cappellen
Journal:  Nucleic Acids Res       Date:  2008-06-25       Impact factor: 16.971

Review 9.  p53, p63 and p73 in the wonderland of S. cerevisiae.

Authors:  Marc Blondel; Cécile Voisset; Olivier Billant
Journal:  Oncotarget       Date:  2017-06-16

Review 10.  Anti-Transcription Factor RNA Aptamers as Potential Therapeutics.

Authors:  Estefanía Mondragón; Louis James Maher
Journal:  Nucleic Acid Ther       Date:  2015-10-28       Impact factor: 5.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.